BlackRock, Inc.

Position in DYN — Dyne Therapeutics, Inc.

CIK 2012383 New York, NY

Position in DYN

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$275,500,161

+$63,381,526 QoQ

Shares Held

12,404,330

+6.0% QoQ

Ownership

6.64%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 245 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 97% Shared 0% None 3%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $85,016,936,299 across 474 Biotechnology names. DYN ranks #62 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	24,109,373	$11,975,848,839
2	REGN	Regeneron Pharmaceuticals, Inc.	9,113,506	$5,682,635,520
3	ALNY	Alnylam Pharmaceuticals, Inc.	10,907,675	$3,283,537,392
4	RVMD	Revolution Medicines, Inc.	13,695,790	$2,564,947,540
5	MRNA	Moderna, Inc.	30,599,409	$2,142,876,602
6	INCY	Incyte Corp	18,032,718	$2,044,188,902
7	CYTK	Cytokinetics Inc	20,094,362	$1,711,838,691
8	ROIV	Roivant Sciences Ltd.	48,236,091	$1,707,075,250

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$275,500,161	12,404,330	+6.0%	Shares	Sole	2026-08-07
2026-06-30	$255,181,883	11,489,504	—	Shares	Sole	2026-07-28
2026-03-31	$212,118,635	11,699,870	+4.5%	Shares	Sole	2026-05-13
2025-12-31	$218,892,782	11,190,838	+16.1%	Shares	Sole	2026-02-12
2025-09-30	$121,881,593	9,634,909	+19.3%	Shares	Sole	2025-11-12
2025-06-30	$76,906,627	8,078,428	+0.4%	Shares	Sole	2025-08-12
2025-03-31	$84,170,965	8,046,938	+1.2%	Shares	Sole	2025-05-02
2024-12-31	$187,287,903	7,949,402	+2.0%	Shares	Sole	2025-02-07
2024-09-30	$279,964,568	7,794,114	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.